Zdrowie i gospodarka · 11/05/2026
Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is actively seeking licensees to develop inhibitory transmembrane adapter proteins for T-cell immunotherapy in treating cancer, infectious diseases, and autoimmune diseases.